Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

このアイテムは取り下げられました。詳細要約

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Hasan Ali, O., Berner, F., Bomze, D., Fässler, M., Diem, S., Cozzio, A., Jörger, M., Früh, M., Driessen, C., Lenz, T. L., & Flatz, L. (2019). Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. European Journal of Cancer, 107, 8-14.

Item is 取り下げ

基本情報 (取り下げ)

取り下げ日: 2019-11-04

コメント: Echte Dublette!!!

作成者:
Hasan Ali, Omar
Berner, Fiamma
Bomze, David
Fässler, Mirjam
Diem, Stefan
Cozzio, Antonio
Jörger, Markus
Früh, Martin
Driessen, Christoph
Lenz, Tobias L.^{1, 2}
Flatz, Lukas

所属:
1Research Group Evolutionary Immunogenomics, Department Evolutionary Ecology, Max Planck Institute for Evolutionary Biology, Max Planck Society, ou_2068286
2Emmy Noether Research Group Evolutionary Immunogenomics, Department Evolutionary Ecology, Max Planck Institute for Evolutionary Biology, Max Planck Society, ou_2068286

日付: 投稿: 2018-08-22受理: 2018-11-01出版: 2019

ファイル: 1 ファイル

関連URL: 0 URL

バージョンID: item_3016547_1

登録状況: 取り下げ

Name of Context: Publications of the MPI for Evolutionary Biology, 所属:: Max Planck Institute for Evolutionary Biology

アイテム詳細

基本情報 (取り下げ)